Metropolis Healthcare Shares Gain Bullish Outlook from Analysts Following Q4 Performance
Metropolis Healthcare, India’s second-largest pathology laboratory chain, has garnered a positive outlook from major brokerage firms Nuvama and Emkay following its fiscal fourth-quarter 2026 results. The company reported a significant 74 percent year-on-year increase in consolidated profit after tax to Rs 50.96 crore, driven by robust demand and improved operational efficiencies. Context of Growth and…
